Skip to content

Vojta therapy in multiple sclerosis rehabilitation

Vojta therapy improves gait and postural control in multiple sclerosis rehabilitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12817871
Enrollment
50
Registered
2022-02-16
Start date
2022-03-07
Completion date
Unknown
Last updated
2022-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis Nervous System Diseases Multiple sclerosis

Interventions

After baseline assessments, the participants will be randomly assigned to: 1. Vojta therapy 2. Standard rehabilitation training The individuals receivi

Sponsors

Opole University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Final diagnosis of MS (by McDonald's criteria) 2. Relapsing-remitting stage of MS 3. Walkability with or without assistance (4.0-6 in Expanded Disability Status Scale [EDSS])

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years old 2. Progressive MS 3. Phase outbreak or outbreak in the 3 months before the study 4. Medication that prevents or limits the performance of the locomotion reflex 5. Non-treated arterial hypertension 6. Cardiopulmonary incompetence 7. Pregnancy 8. Cancer 9. Active infections 10. Hepatitis B and HIV infection 11. Severe articular degeneration, including patients eligible for orthopedic surgery 12. Advanced osteoporosis 13. A history of stroke and Parkinson disease

Design outcomes

Primary

MeasureTime frame
Gait analysed using a medical treadmill at baseline, 4, 8 and 16 weeks

Secondary

MeasureTime frame
1. Pain assessed with the Visual Analogue Scale at baseline, 4, 8 and 16 weeks 2. Balance and postural control assessed with the Berg Balance Scale (BBS) and the Tinetti Test at baseline, 4, 8 and 16 weeks 3. Postural control measured using the Timed Walking Test and 12-item Multiple Sclerosis Walking Scale at baseline, 4, 8 and 16 weeks

Countries

Poland

Contacts

Public ContactLukasz Argier
argier@o2.pl+48 (0)606781243

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026